Historical Valuation
Pediatrix Medical Group Inc (MD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.87 is considered Undervalued compared with the five-year average of 10.99. The fair price of Pediatrix Medical Group Inc (MD) is between 26.53 to 41.41 according to relative valuation methord. Compared to the current price of 22.34 USD , Pediatrix Medical Group Inc is Undervalued By 15.8%.
Relative Value
Fair Zone
26.53-41.41
Current Price：22.34
15.8%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Pediatrix Medical Group Inc (MD) has a current Price-to-Book (P/B) ratio of 2.01. Compared to its 3-year average P/B ratio of 1.31 , the current P/B ratio is approximately 53.59% higher. Relative to its 5-year average P/B ratio of 1.78, the current P/B ratio is about 12.77% higher. Pediatrix Medical Group Inc (MD) has a Forward Free Cash Flow (FCF) yield of approximately 15.25%. Compared to its 3-year average FCF yield of 13.56%, the current FCF yield is approximately 12.47% lower. Relative to its 5-year average FCF yield of 9.84% , the current FCF yield is about 54.96% lower.
P/B
Median3y
1.31
Median5y
1.78
FCF Yield
Median3y
13.56
Median5y
9.84
Competitors Valuation Multiple
AI Analysis for MD
The average P/S ratio for MD competitors is 1.22, providing a benchmark for relative valuation. Pediatrix Medical Group Inc Corp (MD.N) exhibits a P/S ratio of 0.92, which is -24.72% above the industry average. Given its robust revenue growth of -3.58%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for MD
1Y
3Y
5Y
Market capitalization of MD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MD currently overvalued or undervalued?
Pediatrix Medical Group Inc (MD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.87 is considered Undervalued compared with the five-year average of 10.99. The fair price of Pediatrix Medical Group Inc (MD) is between 26.53 to 41.41 according to relative valuation methord. Compared to the current price of 22.34 USD , Pediatrix Medical Group Inc is Undervalued By 15.80% .
What is Pediatrix Medical Group Inc (MD) fair value?
MD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Pediatrix Medical Group Inc (MD) is between 26.53 to 41.41 according to relative valuation methord.
How does MD's valuation metrics compare to the industry average?
The average P/S ratio for MD's competitors is 1.22, providing a benchmark for relative valuation. Pediatrix Medical Group Inc Corp (MD) exhibits a P/S ratio of 0.92, which is -24.72% above the industry average. Given its robust revenue growth of -3.58%, this premium appears unsustainable.
What is the current P/B ratio for Pediatrix Medical Group Inc (MD) as of Jan 10 2026?
As of Jan 10 2026, Pediatrix Medical Group Inc (MD) has a P/B ratio of 2.01. This indicates that the market values MD at 2.01 times its book value.
What is the current FCF Yield for Pediatrix Medical Group Inc (MD) as of Jan 10 2026?
As of Jan 10 2026, Pediatrix Medical Group Inc (MD) has a FCF Yield of 15.25%. This means that for every dollar of Pediatrix Medical Group Inc’s market capitalization, the company generates 15.25 cents in free cash flow.
What is the current Forward P/E ratio for Pediatrix Medical Group Inc (MD) as of Jan 10 2026?
As of Jan 10 2026, Pediatrix Medical Group Inc (MD) has a Forward P/E ratio of 9.87. This means the market is willing to pay $9.87 for every dollar of Pediatrix Medical Group Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Pediatrix Medical Group Inc (MD) as of Jan 10 2026?
As of Jan 10 2026, Pediatrix Medical Group Inc (MD) has a Forward P/S ratio of 0.92. This means the market is valuing MD at $0.92 for every dollar of expected revenue over the next 12 months.